Legal claims defining the scope of protection. Each claim is shown in both the original legal language and a plain English translation.
1. A method comprising: accepting at least one indication of at least one bioactive agent used by an individual; selecting, using one or more computer processors, at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual; and presenting the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent.
A method for detecting the effect of a bioactive agent on an individual. The method involves receiving information about the bioactive agent used by the individual (e.g., type, dosage). Based on this information, the system selects a specific sensory experience (e.g., a visual pattern, an auditory tone, a virtual reality environment). This selected sensory experience is then presented to the individual. The system then monitors or measures the individual's response to the sensory experience to detect the effect of the bioactive agent. This could involve measuring physiological data, behavioral data, or subjective feedback from the individual.
2. A system comprising: means for accepting at least one indication of at least one bioactive agent used by an individual; means for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual; and means for presenting the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent.
A system for detecting the effect of a bioactive agent on an individual. The system includes a component for receiving information about the bioactive agent used by the individual (e.g., type, dosage). It also includes a component for selecting a specific sensory experience (e.g., a visual pattern, an auditory tone, a virtual reality environment) based on the bioactive agent information. Finally, it includes a component for presenting this sensory experience to the individual and monitoring the individual's response to detect the effect of the bioactive agent. This could involve measuring physiological data, behavioral data, or subjective feedback from the individual.
3. A computer program product comprising: one or more non-transitory media including at least: one or more instructions for accepting at least one indication of at least one bioactive agent used by an individual; one or more instructions for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual; and one or more instructions for presenting the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent.
A computer program product for detecting the effect of a bioactive agent on an individual. The product includes instructions for receiving information about the bioactive agent used by the individual (e.g., type, dosage). There are also instructions for selecting a specific sensory experience (e.g., a visual pattern, an auditory tone, a virtual reality environment) based on the bioactive agent information. Finally, there are instructions for presenting this sensory experience to the individual and monitoring the individual's response to detect the effect of the bioactive agent. This could involve measuring physiological data, behavioral data, or subjective feedback from the individual. The instructions are stored on a non-transitory medium.
4. A system comprising: a computing device; and one or more media including at least: one or more instructions for accepting at least one indication of at least one bioactive agent used by an individual; one or more instructions for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual; and one or more instructions for presenting the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent.
A system for detecting the effect of a bioactive agent on an individual. The system includes a computing device and instructions stored on a medium. The instructions are for receiving information about the bioactive agent used by the individual (e.g., type, dosage). There are also instructions for selecting a specific sensory experience (e.g., a visual pattern, an auditory tone, a virtual reality environment) based on the bioactive agent information. Finally, there are instructions for presenting this sensory experience to the individual and monitoring the individual's response to detect the effect of the bioactive agent. This could involve measuring physiological data, behavioral data, or subjective feedback from the individual.
5. A system comprising: circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual; circuitry configured for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual; and circuitry configured for presenting the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent.
A system for detecting the effect of a bioactive agent on an individual. The system contains circuitry for receiving information about the bioactive agent used by the individual (e.g., type, dosage). It also includes circuitry for selecting a specific sensory experience (e.g., a visual pattern, an auditory tone, a virtual reality environment) based on the bioactive agent information. Finally, it includes circuitry for presenting this sensory experience to the individual and monitoring the individual's response to detect the effect of the bioactive agent.
6. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one prescription medication used by an individual.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) specifically includes circuitry for receiving information about prescription medications used by the individual. This expands the types of bioactive agents that the system can process.
7. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one of the following types of bioactive agents used by an individual: an anti-depressant, an anxiolytic medication, a pain medication, a behavior modifying medication, a weight adjustment drug, an anti-Alzheimer's medication, or an anti-stroke medication.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) specifically includes circuitry for receiving information about one or more of the following bioactive agents: anti-depressants, anti-anxiety medication, pain medication, behavior modifying medication, weight adjustment drugs, anti-Alzheimer's medication, or anti-stroke medication.
8. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one bioactive agent abused by an individual.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) specifically includes circuitry for receiving information about bioactive agents that are abused by the individual. This expands the types of bioactive agents that the system can process to include illicit substances.
9. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one of the following types of bioactive agents used by an individual: alcohol, psychoactive drug, tranquilizer, methamphetamine, tobacco, marijuana, or narcotic.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) specifically includes circuitry for receiving information about one or more of the following bioactive agents: alcohol, psychoactive drugs, tranquilizers, methamphetamine, tobacco, marijuana, or narcotics.
10. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one nutraceutical used by an individual.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) specifically includes circuitry for receiving information about nutraceuticals used by the individual. This expands the types of bioactive agents that the system can process to include supplements.
11. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one of the following types of bioactive agents used by an individual: memory supplement, antioxidant, cancer preventative agent, weight adjustment agent, or mood-changing agent.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) specifically includes circuitry for receiving information about one or more of the following bioactive agents: memory supplements, antioxidants, cancer preventative agents, weight adjustment agents, or mood-changing agents.
12. The system of claim 5 , wherein the circuitry configured for accepting at least one indication of at least one bioactive agent used by an individual comprises: circuitry configured for accepting at least one indication of at least one bioactive agent used by at least one of the following types of individuals: a computer game participant, a social networking tool user, a virtual world participant, an online student, an online medical information user, or an on-line shopper.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) specifically includes circuitry for receiving information about the bioactive agent used by specific types of individuals: computer game participants, social networking tool users, virtual world participants, online students, online medical information users, or online shoppers.
13. The system of claim 5 , wherein the circuitry configured for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual comprises: circuitry configured for selecting at least one virtual world experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) includes circuitry specifically configured to select a virtual world experience as the sensory experience based on the bioactive agent information. Instead of a simple visual stimulus, the individual interacts with a virtual environment.
14. The system of claim 5 , wherein the circuitry configured for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual comprises: circuitry configured for selecting at least one of the following types of sensory experiences based at least partly on the at least one indication of the at least one bioactive agent used by the individual: virtual world, social networking, online game, single player game, or online educational experience.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) includes circuitry specifically configured to select one of the following types of sensory experiences: virtual world, social networking experience, online game, single player game, or online educational experience, based on the bioactive agent information.
15. The system of claim 5 , wherein the circuitry configured for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual comprises: circuitry configured for selecting at least one sensory experience based at least partly on at least one attribute of the individual and the at least one indication of the at least one bioactive agent used by the individual.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) includes circuitry specifically configured to select a sensory experience based on both the bioactive agent information *and* individual attributes of the user. For example, age, gender, or pre-existing conditions could affect sensory experience selection.
16. The system of claim 5 , wherein the circuitry configured for selecting at least one sensory experience based at least partly on the at least one indication of the at least one bioactive agent used by the individual comprises: circuitry configured for selecting at least one visual stimulus based at least partly on the at least one indication of the at least one bioactive agent used by the individual.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) includes circuitry specifically configured to select a visual stimulus (e.g., color, pattern, image) as the sensory experience, based on the bioactive agent information.
17. The system of claim 5 , wherein the circuitry configured for presenting the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent comprises: circuitry configured for presenting via at least one mobile device the at least one sensory experience selected based at least partly on the at least one indication of the at least one bioactive agent used by the individual for at least detecting at least one effect of the at least one bioactive agent.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) includes circuitry specifically configured to present the selected sensory experience via a mobile device. This means the experience is delivered through a smartphone or tablet.
18. The system of claim 5 , further comprising: circuitry configured for monitoring for at least one effect of the at least one bioactive agent.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) further includes circuitry for directly monitoring for the effect of the bioactive agent. This circuitry actively looks for changes caused by the agent, augmenting the sensory experience.
19. The system of claim 5 , further comprising: circuitry configured for monitoring one or more of the following aspects: physical activity, body weight, body mass index number, heart rate, blood oxygen level, blood pressure, physiological, neurophysiological, movement, brain activity, behavior, voice, or hearing.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience, and monitoring the effects of the agent) further includes circuitry for monitoring one or more of the following aspects of the user: physical activity, body weight, body mass index number, heart rate, blood oxygen level, blood pressure, physiological aspects, neurophysiological aspects, movement, brain activity, behavior, voice, or hearing.
20. The system of claim 5 , further comprising: circuitry configured for measuring at least one physiologic characteristic.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) further includes circuitry for measuring at least one physiologic characteristic of the user.
21. The system of claim 5 , further comprising: circuitry configured for measuring at least one of physical activity, body weight, body mass index number, heart rate, blood oxygen level, or blood pressure.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) further includes circuitry for measuring at least one of the following physical characteristics: physical activity, body weight, body mass index number, heart rate, blood oxygen level, or blood pressure.
22. The system of claim 5 , further comprising: circuitry configured for measuring neurophysiological activity.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) further includes circuitry for measuring neurophysiological activity in the user's brain.
23. The system of claim 5 , further comprising: circuitry configured for detecting at least one effect of the at least one bioactive agent.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) further includes circuitry configured to directly detect at least one effect of the bioactive agent on the individual.
24. The system of claim 5 , further comprising: circuitry configured for detecting at least one effect of the at least one bioactive agent based at least partly on body movement data.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) further includes circuitry for detecting at least one effect of the bioactive agent based at least partly on the user's body movement data.
25. The system of claim 5 , further comprising: circuitry configured for detecting at least one effect of the at least one bioactive agent based at least partly on physiological data.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) further includes circuitry for detecting at least one effect of the bioactive agent based at least partly on the user's physiological data (e.g., heart rate, blood pressure).
26. The system of claim 5 , further comprising: circuitry configured for detecting at least one effect of the at least one bioactive agent based at least partly on behavior data.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) further includes circuitry for detecting at least one effect of the bioactive agent based at least partly on the user's behavior data.
27. The system of claim 5 , further comprising: circuitry configured for presenting at least one indication of at least one different bioactive agent.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) further includes circuitry for presenting information about a different bioactive agent to the user. This could be used to suggest alternatives or combinations.
28. The system of claim 5 , further comprising: circuitry configured for accepting at least one attribute of the individual.
The system from the previous bioactive agent detection description (which includes circuitry for receiving information about the bioactive agent, selecting a sensory experience, and presenting the experience) further includes circuitry for accepting at least one attribute of the individual (e.g., age, gender, weight, medical history).
Unknown
January 6, 2015
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.